| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241359 | Respiratory Medicine | 2015 | 6 Pages |
Abstract
Albuterol MDPI provides clinically significant protection from EIB in adolescents and adults with EIB; no new safety issues were observed with short-term albuterol MDPI use. ClinicalTrials.gov identifier NCT01791972.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Nancy K. Ostrom, Herminia Taveras, Harald Iverson, David S. Pearlman,